Mirtazapine and Chronic myeloid leukaemia - a phase IV clinical study of FDA data

Summary:

Chronic myeloid leukaemia is found among people who take Mirtazapine, especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Mirtazapine and have Chronic myeloid leukaemia. It is created by eHealthMe based on reports of 65,788 people who have side effects when taking Mirtazapine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

65,788 people reported to have side effects when taking Mirtazapine.
Among them, 8 people (0.01%) have Chronic myeloid leukaemia.

What is Mirtazapine?

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 68,201 Mirtazapine users for its effectiveness, alternative drugs and more.

What is Chronic myeloid leukaemia?

Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood) is found to be associated with 750 drugs and 415 conditions by eHealthMe.

Number of Mirtazapine and Chronic myeloid leukaemia reports submitted per year:

Could Mirtazapine cause Chronic myeloid leukaemia?

Time on Mirtazapine when people have Chronic myeloid leukaemia *:

Gender of people who have Chronic myeloid leukaemia when taking Mirtazapine *:

female: 50 %
male: 50 %

Age of people who have Chronic myeloid leukaemia when taking Mirtazapine *:

Common drugs people take besides Mirtazapine *:

Common side effects people have besides Chronic myeloid leukaemia *:

Thrombocytopenia (decrease of platelets in blood): 2 people, 25.00%
Leukaemia Recurrent (repeat cancer of bone marrow or blood cells): 2 people, 25.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 25.00%
Breathing Difficulty: 2 people, 25.00%
Coughing Up Blood: 2 people, 25.00%
Gangrene (body tissue dies): 2 people, 25.00%
Skin Ulcer: 2 people, 25.00%
International Normalised Ratio Increased: 2 people, 25.00%
Atherosclerosis (disorder of the arteries): 2 people, 25.00%
Pulmonary Haemorrhage (acute bleeding from the lung): 2 people, 25.00%

Common conditions people have *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 12.50%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Mirtazapine and have Chronic myeloid leukaemia?

Check whether Chronic myeloid leukaemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Bacalja J, Ulamec M, Rako D, ?oipi ?, Miji? A, Kru?lin B, "Adrenal gland hemangiosarcoma in a patient with chronic myeloid leukaemia", Int J Case Rep Med, 2013 Jan .

Related studies

How severe was Chronic myeloid leukaemia and when was it recovered:

Chronic myeloid leukaemia in Mirtazapine

Expand to all the drugs that have ingredients of mirtazapine:

Chronic myeloid leukaemia and drugs with ingredients of mirtazapine

Alternative drugs to, pros and cons of Mirtazapine:

Mirtazapine (68,201 reports)

Common Mirtazapine side effects:

Fatigue (feeling of tiredness): 3,977 reports
Stress and anxiety: 3,236 reports
Dizziness: 3,096 reports
Diarrhea: 3,071 reports
Drug ineffective: 3,045 reports
Breathing difficulty: 2,737 reports

Browse all side effects of Mirtazapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Chronic myeloid leukaemia treatments and more:

Chronic myeloid leukaemia (80,039 reports)

COVID vaccines that are related to Chronic myeloid leukaemia:

Common drugs associated with Chronic myeloid leukaemia:

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine (the active ingredients of Mirtazapine) and Mirtazapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.